- Seegene, Selventa Partner on MDx Development for 'Underserved Markets'
April 23, 2013 / GenomeWeb Daily News
- Seegene, DuPont Ink MDx Tech Licensing Deal
December 10, 2012 / GenomeWeb Daily News
- BD, Lab21 Team on Oncology Assays
October 15, 2012 / GenomeWeb Daily News
- Immunexpress, Biocartis, Debiopharm to Further Develop Sepsis MDx
June 19, 2012 / GenomeWeb Daily News
- FDA Approves BioMerieux's BRAF Test as CDx
May 30, 2013 / GenomeWeb Daily News